EXANE DERIVATIVES - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 52 filers reported holding LEAP THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$20,968,000
-23.7%
14,4610.0%0.01%
-37.5%
Q1 2021$27,475,000
-15.6%
14,4610.0%0.01%
-20.0%
Q4 2020$32,536,00014,4610.01%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Perceptive Advisors 16,952,992$27,802,0000.18%
Opaleye Management Inc. 540,000$886,0000.15%
ACT CAPITAL MANAGEMENT, LLC 134,000$220,0000.11%
Artal Group S.A. 3,000,000$4,920,0000.10%
HHLR ADVISORS, LTD. 3,575,745$5,864,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 910,047$1,492,0000.04%
PERSONAL CFO SOLUTIONS, LLC 78,165$128,0000.03%
GSA CAPITAL PARTNERS LLP 122,401$201,0000.02%
Windsor Creek Advisors, LLC 46,955$77,0000.02%
Golden Green, Inc. 14,824$24,0000.02%
View complete list of LEAP THERAPEUTICS INC shareholders